These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 816470)

  • 1. Expression of immunoglobulin synthesis in human myeloma x non-lymphoid cell heterokaryons: evidence for negative control.
    Zeuthen J; Stenman S; Fabricius HA; Nilsson K
    Cell Differ; 1976 Mar; 4(6):369-83. PubMed ID: 816470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The establishment of a human myeloma cell line elaborating lambda-light chain protein.
    Niho Y; Shibuya T; Yamasaki K; Kimura N
    Int J Cell Cloning; 1984 May; 2(3):161-72. PubMed ID: 6429256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleolus-associated localization of J chains in IgG 1(lambda)-producing myeloma cells.
    Kanoh T; Ohnaka T; Yasuda N; Uchino H
    Am J Clin Pathol; 1985 May; 83(5):577-81. PubMed ID: 3922215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations affecting immunoglobulin light chain secretion by myeloma cells. I. Functional analysis by cell fusion.
    Mosmann TR; Baumal R; Williamson AR
    Eur J Immunol; 1979 Jul; 9(7):511-6. PubMed ID: 115698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.
    Gallart T; Bladé J; Martínez-Quesada J; Sierra J; Rozman C; Vives J
    Immunology; 1985 May; 55(1):45-57. PubMed ID: 3922877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse lambda 1 hybridomas.
    Geckeler WR; Raschke WC; DiPauli R; Cohn M
    Curr Top Microbiol Immunol; 1978; 81():140-1. PubMed ID: 99288
    [No Abstract]   [Full Text] [Related]  

  • 7. Existence of both kappa and lambda light chain messenger RNA sequences in mouse myeloma, MOPC-104E, known as a lambda chain producer.
    Ono M; Kawakami M
    Biochem Biophys Res Commun; 1977 Jan; 74(2):796-802. PubMed ID: 402138
    [No Abstract]   [Full Text] [Related]  

  • 8. Kinetics of human light chain synthesis by human-mouse myeloma hybrids.
    Cieplinski W; Wardwell J; Schwink AM
    Cancer Biochem Biophys; 1983 Dec; 7(1):1-10. PubMed ID: 6421474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoplasmacytic myeloma: an immunological, immunohistochemical and electron microscopic study.
    Sun NC; Fishkin BG; Nies KM; Glassy EF; Carpentier C
    Cancer; 1979 Jun; 43(6):2268-78. PubMed ID: 110436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybridization of a human myeloma permanent cell line with mouse cells.
    Zeuthen J; Nilsson K
    Cell Differ; 1976 Mar; 4(6):355-68. PubMed ID: 944100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and translation of an immunoglobulin lambda chain messenger RNA from mouse myeloma.
    Honjo T; Swan D; Packman S; Polsky F; Leder P
    Biochemistry; 1976 Jun; 15(13):2775-9. PubMed ID: 59605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
    Jensen GS; Belch AR; Kherani F; Mant MJ; Ruether BA; Pilarski LM
    Scand J Immunol; 1992 Dec; 36(6):843-53. PubMed ID: 1281335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic cell hybridization of mouse myeloma cells.
    Margulies DH; Kuehl WM; Scharff MD
    Cell; 1976 Jul; 8(3):405-15. PubMed ID: 821618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytic, lambda light chain, plasma cell myeloma.
    Wirt DP; Grogan TM; Payne CM; Kummet TD; Durie BG; Finley PR; Rollins D
    Am J Clin Pathol; 1983 Jul; 80(1):75-84. PubMed ID: 6190396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo growth advantage of the MOPC-315 mouse myeloma over its immunoselected variants.
    Hannestad K; Kao MS; Lynch RG; Eisen HN
    J Natl Cancer Inst; 1977 Oct; 59(4):1307-10. PubMed ID: 409851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Light chain isotype associated suppression of surface immunoglobulin expression on peripheral blood lymphocytes in myeloma during plateau phase.
    Wearne A; Joshua DE; Kronenberg H
    Br J Haematol; 1984 Nov; 58(3):483-9. PubMed ID: 6437432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of light chain synthesis in myeloma x spleen cell hybrids and identification of myeloma chain loss variants using radioimmunoassay.
    Springer TA
    J Immunol Methods; 1980; 37(2):139-52. PubMed ID: 6777428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a secretory block in a case of CLL with IgA lambda crystalline inclusions.
    Gordon J; Smith JL
    Br J Haematol; 1979 Sep; 43(1):155-6. PubMed ID: 116670
    [No Abstract]   [Full Text] [Related]  

  • 19. Glutamine as a precursor to N-terminal pyrrolid-2-one-5-carboxylic acid in mouse immunoglobulin lambda-type light chains. Amino acid-sequence variability at the N-terminal extra piece of lambda-type light-chain precursors.
    Burstein Y; Schechter I
    Biochem J; 1977 Aug; 165(2):347-54. PubMed ID: 411485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double light-chain production by leukemic cells of common clonal origin: a case report with review of pertinent literature.
    Choi YJ; Wong MS
    Am J Hematol; 1981; 11(1):93-8. PubMed ID: 6791496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.